3B's Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, Avepark - Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco - Guimarães, Portugal.
Nanoscale. 2018 Sep 20;10(36):17388-17401. doi: 10.1039/c8nr04273j.
The extracellular matrix (ECM)-biomimetic fibrillar structure of platelet lysate (PL) gels along with their enriched milieu of biomolecules has drawn significant interest in regenerative medicine applications. However, PL-based gels have poor structural stability, which severely limits their performance as a bioinstructive biomaterial. Here, rod-shaped cellulose nanocrystals (CNC) are used as a novel approach to modulate the physical and biochemical microenvironment of PL gels enabling their effective use as injectable human-based cell scaffolds with a level of biomimicry that is difficult to recreate with synthetic biomaterials. The incorporation of CNC (0 to 0.61 wt%) into the PL fibrillar network during the coagulation cascade leads to decreased fiber branching, increased interfiber porosity (from 66 to 83%) and modulates fiber (from 1.4 ± 0.7 to 27 ± 12 kPa) and bulk hydrogel (from 18 ± 4 to 1256 ± 82 Pa) mechanical properties. As a result of these physicochemical alterations, nanocomposite PL hydrogels resist the typical extensive clot retraction (from 76 ± 1 to 24 ± 3 at day 7) and show favored retention of PL bioactive molecules. The feedback of these cues on the fate of human adipose-derived stem cells is evaluated, showing how it can be explored to modulate the commitment of encapsulated stem cells toward different genetic phenotypes without the need for additional external biological stimuli. These fibrillar nanocomposite hydrogels allow therefore the exploration of the outstanding biological properties of human-based PL as an efficient engineered ECM which can be tailored to trigger specific regenerative pathways in minimal invasive strategies.
血小板裂解液 (PL) 凝胶的细胞外基质 (ECM)-仿生纤维结构及其丰富的生物分子环境在再生医学应用中引起了极大的兴趣。然而,PL 基凝胶的结构稳定性差,严重限制了其作为生物指导生物材料的性能。在这里,棒状纤维素纳米晶体 (CNC) 被用作一种新方法来调节 PL 凝胶的物理和生化微环境,使其能够有效地用作可注射的基于人类的细胞支架,其仿生水平难以用合成生物材料重现。在凝结级联过程中,将 CNC(0 至 0.61wt%)掺入 PL 纤维状网络中,会导致纤维分支减少,纤维间孔隙率增加(从 66%增加到 83%),并调节纤维(从 1.4±0.7kPa 增加到 27±12kPa)和块状水凝胶(从 18±4kPa 增加到 1256±82kPa)的机械性能。由于这些理化性质的改变,纳米复合 PL 水凝胶抵抗典型的广泛凝结回缩(从第 7 天的 76±1%减少到 24±3%),并显示出对 PL 生物活性分子的有利保留。评估这些线索对人脂肪来源干细胞命运的反馈,展示了如何探索其对封装干细胞向不同遗传表型的定向分化,而无需额外的外部生物刺激。因此,这些纤维状纳米复合水凝胶允许探索基于人的 PL 的出色生物学特性,作为一种有效的工程 ECM,可根据需要触发特定的再生途径,以实现微创策略。